research use only

Cyperotundone

Cat.No.S3303

Cyperotundone (CYT) is an active constituent in Chuanxiong Rhizoma and Cyperi Rhizoma (CRCR) for treating migraine.
Cyperotundone Chemical Structure

Chemical Structure

Molecular Weight: 218.33

Jump to

Quality Control

Batch: Purity: 99.32%
99.32

Solubility

In vitro
Batch:

DMSO : 44 mg/mL (201.52 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 44 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 218.33 Formula

C15H22O

Storage (From the date of receipt) 2 years -20°C liquid
CAS No. 3466-15-7 -- Storage of Stock Solutions

Synonyms CYT Smiles CC1CCC2CC3=C(C)C(=O)CC13C2(C)C

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT04927169 Terminated
COVID-19|Lymphocytopenia
Revimmune|C.R.O. ReSolution Latin America S.A.
March 1 2021 Phase 2
NCT04426201 Terminated
COVID-19|Lymphocytopenia
Revimmune|Memorial Sloan Kettering Cancer Center|Amarex Clinical Research|M.D. Anderson Cancer Center|Cancer Research Institute New York City
December 20 2020 Phase 2
NCT04154826 Terminated
Mycobacterium Infections Nontuberculous
Revimmune|Washington University School of Medicine
November 30 2020 Phase 2
NCT04442178 Terminated
COVID-19|Lymphocytopenia
Revimmune|Washington University School of Medicine|Amarex Clinical Research
September 15 2020 Phase 2

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.